Birdwatch Note
2024-10-14 07:30:23 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
A study suggests ivermectin may reduce ovarian cancer growth in lab settings by affecting specific molecular pathways. However, this is based on lab experiments, & there is no clinical evidence for ivermectin or fenbendazole as cancer cures. More research is needed. Read more: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7272521/
Written by E317EB1518013F98AC93FCCF13AEBEF8184DCB58C7A469A34CC14F98A0582F8E
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1845143655025344863
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1845728845699190899
- noteId - 1845728845699190899
- participantId -
- noteAuthorParticipantId - E317EB1518013F98AC93FCCF13AEBEF8184DCB58C7A469A34CC14F98A0582F8E Participant Details
- createdAtMillis - 1728891023456
- tweetId - 1845143655025344863
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- A study suggests ivermectin may reduce ovarian cancer growth in lab settings by affecting specific molecular pathways. However, this is based on lab experiments, & there is no clinical evidence for ivermectin or fenbendazole as cancer cures. More research is needed. Read more: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7272521/
Note Ratings
| rated at | rated by | |
| 2024-10-15 22:43:47 -0500 | Rating Details | |
| 2024-10-15 21:26:03 -0500 | Rating Details | |
| 2024-10-14 15:30:54 -0500 | Rating Details | |
| 2024-10-14 10:18:00 -0500 | Rating Details | |
| 2024-10-14 04:17:57 -0500 | Rating Details | |
| 2024-10-14 06:14:58 -0500 | Rating Details | |
| 2024-10-15 16:59:51 -0500 | Rating Details | |
| 2024-10-14 22:59:28 -0500 | Rating Details | |
| 2025-01-08 18:42:38 -0600 | Rating Details | |
| 2025-01-08 16:12:16 -0600 | Rating Details | |
| 2025-01-08 15:09:34 -0600 | Rating Details | |
| 2025-01-08 14:14:34 -0600 | Rating Details | |
| 2025-01-08 13:57:14 -0600 | Rating Details | |
| 2025-01-08 13:39:46 -0600 | Rating Details | |
| 2025-01-08 11:59:21 -0600 | Rating Details | |
| 2025-01-08 10:18:09 -0600 | Rating Details | |
| 2025-01-08 08:54:04 -0600 | Rating Details | |
| 2025-01-08 07:29:21 -0600 | Rating Details | |
| 2025-01-08 06:02:20 -0600 | Rating Details | |
| 2025-01-09 09:22:37 -0600 | Rating Details | |
| 2025-01-09 08:34:18 -0600 | Rating Details | |
| 2025-01-14 02:01:43 -0600 | Rating Details | |
| 2025-01-12 08:03:37 -0600 | Rating Details | |
| 2025-01-09 06:01:54 -0600 | Rating Details | |
| 2025-01-09 05:00:22 -0600 | Rating Details | |
| 2025-01-12 06:15:53 -0600 | Rating Details | |
| 2025-01-08 22:57:12 -0600 | Rating Details | |
| 2025-01-08 04:30:59 -0600 | Rating Details | |
| 2025-01-07 21:58:25 -0600 | Rating Details | |
| 2025-01-12 13:30:10 -0600 | Rating Details | |
| 2025-01-11 22:19:12 -0600 | Rating Details | |
| 2025-01-08 09:01:34 -0600 | Rating Details | |
| 2025-01-08 17:14:38 -0600 | Rating Details | |
| 2025-01-08 13:35:52 -0600 | Rating Details | |
| 2025-01-08 04:42:24 -0600 | Rating Details |